Toward Structure-based Drug-Discovery for SETBP1

Awardee: Jerome Baudry

Institution: The University of Alabama in Huntsville

Grant Amount: $45,733

Funding Period: February 1, 2022 - January 31, 2023


Summary:

We will start the first drug discovery pipeline toward finding a pharmaceuticals that can counter the effect of SETBP1 mutations. We will use very powerful computers to predict how mutated SETBP1 interacts with its partners in the cell, and we will identify small molecules that can correct the problems.

Previous
Previous

Identifying SETBP1 haploinsufficiency molecular pathways to improve patient diagnosis and treatment.

Next
Next

Exercise as Medicine in Cystic Fibrosis: A pilot study assessing the impact of a telehealth exercise program on adherence and self-efficacy